CLINICAL_TRIALS
trial_result
· 2024-05-22
Clinical Trial Update: A Study of Tirzepatide in Overweight and Very Overweight Participants [Phase 1]
Summary
Phase 1 study of tirzepatide in overweight and very overweight participants has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Obesity, Overweight | Phase 1 | Status: COMPLETED | Results posted: 2024-05-22